Epstein-Barr Virus–Associated Posttransplantation Lymphoproliferative Disorder after High-Dose Immunosuppressive Therapy and Autologous CD34-Selected Hematopoietic Stem Cell Transplantation for Severe Autoimmune Diseases

High-dose immunosuppressive therapy followed by autologous hematopoietic stem cell transplantation (HSCT) is currently being evaluated for the control of severe autoimmune diseases. The addition of antithymocyte globulin (ATG) to high-dose chemoradiotherapy in the high-dose immunosuppressive therapy...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Nash, Richard A., Dansey, Roger, Storek, Jan, Georges, George E., Bowen, James D., Holmberg, Leona A., Kraft, George H., Mayes, Maureen D., McDonagh, Kevin T., Chen, Chien-Shing, DiPersio, John, LeMaistre, C. Fred, Pavletic, Steven, Sullivan, Keith M., Sunderhaus, Julie, Furst, Daniel E., McSweeney, Peter A.
Format: Artigo
Jezik:Inglês
Izdano: 2003
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2956744/
https://ncbi.nlm.nih.gov/pubmed/14506660
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items